Events and Webinars
Find details of our upcoming and past events and webinars listed here.
Event: #MCAW2021 - Summary Session
Sunday 7th November, 6.00 - 7.30pm
Online Webinar
A look into the findings from across Medical Cannabis Awareness Week 2021, mapping out calls to action and next steps.
Part of Medical Cannabis Awareness Week 2021
#MCAW2021
Event: #MCAW2021 - Diversity Discussions
Saturday 6th November, 6.00 - 7.30pm
Online Webinar
An open dialogue addressing cultural challenges and the urgent need to widen diversity in the medical cannabis sector.
Part of Medical Cannabis Awareness Week 2021
#MCAW2021
Event: #MCAW2021 - Access Analysis
Friday 5th November, 6.00 - 7.30pm
Online Webinar
A step-by-step guide to support patients in making an informed decision in accessing medical cannabis treatment.
Part of Medical Cannabis Awareness Week 2021
#MCAW2021
Event: #MCAW2021 - Industry Insights
Thursday 4th November, 6.00 - 7.30pm
Online Webinar
An insight into current industry ongoings, focusing on the need to centre and amplify patients in the medical cannabis sector.
Part of Medical Cannabis Awareness Week 2021
#MCAW2021
Event: #MCAW2021 - Research Roundtable
Wednesday 3rd November, 6.00 - 7.30pm
Online Webinar
A look at the latest research, highlighting the real need for real-world evidence in evolving medical cannabis access.
Part of Medical Cannabis Awareness Week 2021
#MCAW2021
Event: #MCAW2021 - Condition Conversations
Tuesday 2nd November, 6.00 - 7.30pm
Online Webinar
A conversation exploring the potential of medical cannabis treatment for a range of physical and mental health conditions.
Part of Medical Cannabis Awareness Week 2021
#MCAW2021
Event: #MCAW2021 - Patient Perspectives
Monday 1st November, 6.00 - 7.30pm
Online Webinar
A patient and parent panel share both the successes and continued barriers in accessing medical cannabis in the UK.
Part of Medical Cannabis Awareness Week 2021
#MCAW2021
Event: Medical Cannabis Awareness Week 2021
Monday 1st - Sunday 7th November
Online Webinar Series
With just three NHS prescriptions having been issued three years on from the law change allowing doctors to prescribe medical cannabis, Medical Cannabis Awareness Week 2021 aims to highlight the real need for real-world evidence in evolving access to this new treatment.
With last year's events involving over 50 speakers and 1500 live attendees, with 60,000 people reached, PLEA is once again collaborating with patients, doctors, colleagues and organisations from across the sector.
Event: Medical cannabis, THC and mental health explored
Thursday 23rd September 6.00 - 7.00pm
Online Panel
Join PLEA Management Committee member Pious, hosted by The Medical Cannabis Clinicians Society and The Medical Cannabis Clinics, as we explore the benefits, myths and current understanding behind THC-rich medical cannabis and mental health conditions including anxiety.
Also joining the panel are Dr Niraj Singh, Consultant Psychiatrist at The Medical Cannabis Clinics and Hannah Deacon, Director at The Medical Cannabis Clinicians Society.
Product Earth
Friday 20th - Sunday 22nd August
Exhibition and Panel
PLEA is looking forward to hosting a patient and carer panel at this years Product Earth event, exploring patient access, research and what patients, carers and supporters can do to further challenge the inequalities in access.
Joining the panel are MedCan Support's Matt Hughes, PLEA Advisory Board member Dr Callie Seaman, Management Committee member Pious, Patient Working Group member Maz Mills and Chair Abby Hughes.
Women's Health And Cannabis Medicines: Motherhood
Tuesday 3rd August 7.00 - 8.30pm
Online Panel
This series explores the experience of women and mothers who have struggled to feel supported by the healthcare system in their or their children’s journeys to diagnosis.
Aimed at clinicians, patients and the general public, the series aims to discuss the application of cannabis medicines in the management of complex female health conditions, and to highlight some of the wider issues surrounding gender inequalities played in our modern medical model.
GCI Virtual Summit: Understanding the Needs of Patients from the Patients Themselves
Wednesday 9th June 1.00 - 1.45pm
Online Panel
Bringing together 1500 global leaders across each sector of cannabis and psychedelics, GCI Virtual Summit gives the opportunity to participate in talks and network with leaders.
PLEA Management Committee member Matthew joins GCI and Patient Advocate Nikki Lawley for the "Understanding the Needs of Patients from the Patients Themselves" panel.
New and Minor Cannabinoids: What Are They and How Can They be Used to Treat Patients?
Tuesday 18th May 3.15 - 4.00pm
Online Panel
We take a deeper look at the specific new Cannabinoids being discovered alongside key researchers - opening up the discussion for an exclusive Live Q&A.
Join our panelists for an accessible overview of the latest cannabinoid research and allow our experts to guide you through some of the exciting potential novel applications.
Women's Health And Cannabis Medicines: Women in Pain EO1
Wednesday 12th May 7.00 - 8.30pm
Online Panel
This series explores the experience of women who have struggled to feel supported by the healthcare system in their journeys to diagnosis.
Aimed at both clinicians, patients and the general public the series aims to discuss the application of cannabis medicines in the management of complex female health conditions, and to highlight some of the wider issues surrounding gender inequalities played in our modern medical model.
NICE Guidelines on Chronic Pain: Help or Hindrance?
Wednesday 28th April 7.00 - 8.00pm
Online Panel
A review of NICE guidance on the assessment and management of Chronic Pain and what this means for professionals and patient in the UK.
Key topics
• A summary of the guidance published by NICE
• Practical implications
• What this guidance means for the rapidly emerging field of Medical Cannabis
Hosted by Sapphire Medical Clinics and Primary Care Cannabis Network.
As a non-profit organisation, PLEA will only invest in projects that address accelerating access to prescribed CBMPs. We shall advocate for the patient community whilst remaining impartial and are not incentivised, influenced or motivated by financial gain. Our resources are offered to patients free of charge.